HIKAL - Hikal | Wealthrox

Hikal

HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com

Stock Price vs Company Growth

1.3%

5.2%

4.5%

16.5%

29.6%

34.8%

27.2%

10y

15.7%

all

13.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 375 1.3%

309

411

Company Overview

Sales

1,803 Cr

Growth: -8.0%

Profit after Tax

67.8 Cr

Growth: -2.6%

Small Cap

4,623 Cr

P/E: 68.2x

Industry P/E: 41.6x

Fundamentals

Sales (Cr)	₹ 1,803
Growth	-8.0%
EBITDA	15.2%
P/S	2.6x
Dividend	0.4%
P/E	68.2x
Book Value	₹ 96.7
PEG Ratio	-8.5x
ROE	5.8%
P/B	3.8x

Shareholding Pattern

Institutions

Government Pension Fund Global

2.31 %

Promoters

Kalyani Investment Company Limited

31.36 %

Shri Badrinath Investment Pvt Ltd

16.15 %

Shri Rameshwara Investment Pvt Ltd

7.96 %

Sugandha Jai Hiremath

7.84 %

Bf Investment Limited

2.65 %

Others

Si Investments And Broking Private Limited

1.62 %

Llp

0.4 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.

Belongs to (6 Indices) view more

Investors (60)

himalaya...

iepf

idfc.ste...

Followers (5)

mike2

nitin29

vishal48